102 results
Page 3 of 6
S-8
uohn2783ioo9l0b3o0
13 May 22
Registration of securities for employees
10:25am
S-8
EX-23.1
j55pcs 8fb5sp8pp
13 May 22
Registration of securities for employees
10:25am
10-K/A
entxmec2
29 Apr 22
Annual report (amended)
4:43pm
DEFC14A
k4lviqp g0agc0c
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
gyi mx12to
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PREC14A
tibx7
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
klu0uffdcnhj0lst uu3
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
fhbbn71x3paz8xhs 3mv
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
EX-10.5
yw266b 39rcw
31 Mar 22
Annual report
8:18am
10-K
EX-10.11
axdue
31 Mar 22
Annual report
8:18am
10-K
jek82kuh qtku
31 Mar 22
Annual report
8:18am
10-K
EX-23.1
3v3w83hdvdb yblajie
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
l077vq5g11xv8u936e
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
EX-99.1
z8y4j
21 Mar 22
Departure of Directors or Certain Officers
6:32am
8-K/A
EX-99.1
6kgqdxjh uoqlsc9wwsd
21 Mar 22
Departure of Directors or Certain Officers
6:30am
8-K
EX-99.1
ie2ovoqgwybix
13 Jan 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
ikd5s5l msic1y0
15 Nov 21
Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results
8:08am